Hologic Inc
NASDAQ:HOLX
Hologic Inc
Cash from Operating Activities
Hologic Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Hologic Inc
NASDAQ:HOLX
|
Cash from Operating Activities
$1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
52%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Hologic Inc's Cash from Operating Activities?
Cash from Operating Activities
1B
USD
Based on the financial report for Dec 30, 2023, Hologic Inc's Cash from Operating Activities amounts to 1B USD.
What is Hologic Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
8%
Over the last year, the Cash from Operating Activities growth was -44%. The average annual Cash from Operating Activities growth rates for Hologic Inc have been -11% over the past three years , 9% over the past five years , and 8% over the past ten years .